Rossari Biotech Limited has reported consolidated financial results for the period ended September 30, 2024.

Rossari Biotech has posted net profit of Rs. 35.33 crores for the period ended September 30, 2024 as against net profit of Rs. 34.89 crores for the period ended June 30, 2024. The company posted net profit of Rs.32.94 crores for the period ended September 30, 2023.

Commenting on the performance, in a joint statement, Edward Menezes, Promoter & Executive Chairman, and Sunil Chari, Promoter & Managing Director, said
“We have reported a steady performance this quarter, reflecting the resilience of our business amidst a dynamic market environment. Our HPPC division continues to demonstrate consistent growth, while the Textile business is still navigating headwinds, with a recovery expected in the next calendar year. AHN Business remained stable during the quarter.

On the export front, we are proud to have expanded our global operations, with several geographies emerging as key drivers of future growth. We registered a strong performance in our export markets by targeting new customers in both new and existing geographies and increasing our wallet share with our partners. In H1 FY25, exports grew by 32%, providing support to overall performance amidst softer domestic growth. While the domestic market is also poised for expansion, we expect exports to outpace domestic growth, further strengthening our position in international markets.

We continue to pioneer intelligent and sustainable solutions across industries, enhancing everyday life through our eco-friendly and technology-driven offerings. Our focus on innovation and customer-centric solutions enables us to stay ahead of industry trends, delivering value through products that are both high in quality and sustainability.

With a diversified product portfolio, agile manufacturing capabilities, and a strong balance sheet, we believe we are well-positioned to capitalize on emerging opportunities and drive healthy growth for the foreseeable future. As a growth-focused Company, we remain committed to innovation, continuously developing tailored solutions that meet the evolving needs of our customers. We are working towards expanding our global footprint through our own manufacturing set up and sales & distribution network overseas. This approach strengthens our confidence in delivering sustainable operational and financial performance while creating long-term value for all our stakeholders.”

Rossari Biotech has reported total income of Rs. 499.07 crores during the period ended September 30, 2024 as compared to Rs. 490.59 crores during the period ended June 30, 2024. The company reported total income of Rs. 484.832 crores during the period ended September 30, 2023.

For the Half Year ended FY2025, Rossari Biotech has reported total income of Rs. 989.66 crores as compared to Rs. 897.62 crores during the 6 months period ended September 30, 2023.

Rossari Biotechhas posted net profit of Rs. 70.23 crores for the 6 months period ended September 30, 2024 as against net profit of Rs. 62.167 crores for the 6 months period ended September 30, 2023.